GPIGBP1 autoantibody syndrome was found in the patients with multiple sclerosis treated with interferon β1a, who developed severe hypertriglyceridemia and very low plasma levels of GPIHBP1 and LPL.43 This evidence concerns the gene GPIHBP1 and hypertriglyceridemia.